 Determination erythrocyte-bound acetylcholinesterase activity pyridostigmine therapy myasthenia gravis Monitoring pyridostigmine therapy patients myasthenia gravis daily pyridostigmine doses patient actual clinical status plasma concentrations PPC PPC determination time-consuming much technical equipment pyridostigmine reversible blocks acetylcholinesterase AChE neuromuscular junction correlation enzyme blood activity erythrocyte-bound AChE PPC hand blood AChE activity clinical status individual patient untreated patients myasthenia gravis blood AChE activity accordance actual PPC single oral dose mg pyridostigmine group Amelioration clinical status decrease AChE activity way patients stable pyridostigmine medication week AChE activity PPC constant day group PPC results determination AChE activity superior PPC cholinesterase inhibitor therapy cases